• Corpus ID: 5672747

Natural and synthetic coumarins as potential anticancer agents

@article{Klenkar2015NaturalAS,
  title={Natural and synthetic coumarins as potential anticancer agents},
  author={Jelena Klenkar and Maja Molnar},
  journal={Journal of chemical and pharmaceutical research},
  year={2015},
  volume={7},
  pages={1223-1238}
}
Coumarins, natural or synthetic, due to their wide range of biological activities, have become an interesting subject of investigation for many researchers. Coumarin scaffold has proven to have an important role in anticancer drug development due to a fact that many of its derivatives have shown an anticancer activity on various cell lines. Action of coumarins on tumour cells is carried out via different mechanisms and some of them show very good selectivity toward the cancer cells. In this… 

Some Important Coumarin Derivatives and Their Pharmacological Activities

TLDR
This review article provides recent informations and pharmacological activities of some important coumarins either fused or linked with heterocycle scaffolds.

COUMARINS: A UNIQUE SCAFFOLD WITH VERSATILE BIOLOGICAL BEHAVIOR

TLDR
This review comprised pharmacokinetic studies, including absorption, distribution, and metabolism of coumarin analogs along with toxicological studies, which exhibited impressive pharmacological and physiological activities such as anticoagulant, antibacterial, antiviral, antitumor, bactericidal, fungicidal, anti-inflammatory agents, and anti-HIV activity.

An insight into the therapeutic applications of coumarin compounds and their mechanisms of action.

  • S. GargJ. GuptaShikha SharmaD. Sahu
  • Chemistry, Biology
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2020

Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds

TLDR
An overview of the most recent synthetic pathways leading to mono- and polyfunctionalized coumarins will be presented, along with the main biological pathways of their biosynthesis and metabolic transformations.

Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives

TLDR
3-arylcoumarins can be recognised as useful structures for the design of novel compounds with potential pharmacological interest, particularly in the fields of anti-inflammatory, anti-cancer, antioxidant, Monoamine oxidase (MAO) enzyme inhibition, etc.

Antagonists of Vitamin K—Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives

TLDR
This interdisciplinary review presents biochemical principles of the coagulation processes and possible methods for their tuning based on the use of coumarins and discusses structures and properties of those that have been used for a long time, as well as newly synthesized compounds.

Biochemical Studies on Coumarin Derivatives as Antioxidant and Antitumor Agents

Background: Coumarin derivatives have attracted intense interest in recent years, because they have anti-tumor, antioxidant activities, and induce apoptosis. Aims and Objective: Our study aims to

Preparation and Analysis of Coumarin Compound for New Application

Numerous normally occurring substances usually applied in famous drugs the world over, incorporate the coumarin moiety. Coumarin speaks to a unique platform for restorative scientists, in light of
...

References

SHOWING 1-10 OF 43 REFERENCES

How Taxol/paclitaxel kills cancer cells

  • B. Weaver
  • Biology, Medicine
    Molecular biology of the cell
  • 2014
TLDR
Recent evidence demonstrates that intratumoral concentrations of paclitaxel are too low to cause mitotic arrest and result in multipolar divisions instead, and it is hoped that this insight can be used to develop a biomarker to identify the ∼50% of patients that will benefit from pac litaxel therapy.

Bioorg

  • Med. Chem.
  • 2012

DARU J

  • Pharm. Sci.
  • 2014

Bioorg

  • Med. Chem. Lett.
  • 2014

Anticancer Agents Med

  • Chem. 2014,
  • 2014

Bioorg

  • Med. Chem. Lett.
  • 2010

Bioorg

  • Med. Chem.
  • 2010

Chem

  • Biol. Interact.
  • 2014

Invest

  • New Drugs
  • 2011